It is currently approved only for type 2 diabetes mellitus (Mounjaro) and chronic weight management (Zepbound), and any potential addiction-related benefits remain investigational
Gradual dietary fiber increase (to 2535 grams daily for women, 38 grams for men) supports bowel regularity, but fiber must be introduced slowly alongside GLP-1 therapy to avoid bloating and gas
It is important to note that these side effects are not very common and can often be managed effectively [61, 68,69,70,71]
Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al
Ultimately, by linking mechanistic insights to treatment development, these efforts hold promise for advancing more effective interventions and reducing the burden of this prevalent and debilitating condition